Long-term exposure to inorganic arsenic (iAs) through drinking water has been associated with cognitive impairment in children and adults; however, the related pathogenic mechanisms have not been completely described. Increased or chronic inflammation in the brain is linked to impaired cognition and neurodegeneration; iAs induces strong inflammatory responses in several cells, but this effect has been poorly evaluated in central nervous system (CNS) cells. Because astrocytes are the most abundant cells in the CNS and play a critical role in brain homeostasis, including regulation of the inflammatory response, any functional impairment in them can be deleterious for the brain. We propose that iAs could induce cognitive impairment through inflammatory response activation in astrocytes. In the present work, rat cortical astrocytes were acutely exposed in vitro to the monomethylated metabolite of iAs (MMA(III)), which accumulates in glial cells without compromising cell viability. MMA(III) LD50 in astrocytes was 10.52 μM, however, exposure to sub-toxic MMA(III) concentrations (50-1000 nM) significantly increased IL-1β, IL-6, TNF-α, COX-2, and MIF-1 gene expression. These effects were consistent with amyloid precursor protein (APP) and β-secretase (BACE-1) increased gene expression, mainly for those MMA(III) concentrations that also induced TNF-α over-expression. Other effects of MMA(III) on cortical astrocytes included increased proliferative and metabolic activity. All tested MMA(III) concentrations led to an inhibition of intracellular lactate dehydrogenase (LDH) activity. Results suggest that MMA(III) induces important metabolic and functional changes in astrocytes that may affect brain homeostasis and that inflammation may play a major role in cognitive impairment-related pathogenicity in As-exposed populations.

Alzheimer’s disease (AD) is a highly complex and rapidly progressive neurodegenerative disorder characterized by the systemic collapse of cognitive function and formation of dense amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs). AD pathology is derived from the cholinergic, amyloid and tau hypotheses, respectively. Current pharmacotherapy with known anti-cholinesterases, such as Aricept ® and Exelon ®, only offer symptomatic relief without any disease-modifying effects (DMEs). It is now clear that in order to prevent the rapid progression of AD, new therapeutic treatments should target multiple AD pathways as opposed to the traditional “one drug, one target” approach. This research project employed medicinal chemistry tools to develop multifunctional small organic molecules against three key targets of AD pathology – the cholinesterases (AChE and BuChE), AChE-induced and self-induced Aβ1-40 aggregation and generation (β-secretase). A chemical library composed of 112 derivatives was generated to gather structure-activity relationship (SAR) data. The derivatives were based on a novel, non-fused, 2,4-disubstituted pyrimidine ring (2,4-DPR) template with substituents at the C-2 and C-4 position varying in size, steric and electronic properties. Molecular modeling was utilized to investigate their binding modes within the target enzymes and along with the acquired SAR, the chemical library was screened to identify lead multifunctional candidates.

Alzheimer’s disease (AD) is a highly complex and rapidly progressive neurodegenerative disorder characterized by the systemic collapse of cognitive function and formation of dense amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs). AD pathology is derived from the cholinergic, amyloid and tau hypotheses, respectively. Current pharmacotherapy with known anti-cholinesterases, such as Aricept ® and Exelon ®, only offer symptomatic relief without any disease-modifying effects (DMEs). It is now clear that in order to prevent the rapid progression of AD, new therapeutic treatments should target multiple AD pathways as opposed to the traditional “one drug, one target” approach. This research project employed medicinal chemistry tools to develop multifunctional small organic molecules against three key targets of AD pathology – the cholinesterases (AChE and BuChE), AChE-induced and self-induced Aβ1-40 aggregation and generation (β-secretase). A chemical library composed of 112 derivatives was generated to gather structure-activity relationship (SAR) data. The derivatives were based on a novel, non-fused, 2,4-disubstituted pyrimidine ring (2,4-DPR) template with substituents at the C-2 and C-4 position varying in size, steric and electronic properties. Molecular modeling was utilized to investigate their binding modes within the target enzymes and along with the acquired SAR, the chemical library was screened to identify lead multifunctional candidates.

No description available.

La synthèse contrôlée par la cible sous contrôle cinétique (Kinetic Target-Guided Synthesis, KTGS) est une approche relativement peu explorée, alternative à la chimie combinatoire traditionnelle,dans laquelle la protéine cible participe à la synthèse du ou de ses propres ligands. Ainsi, les travaux présentés dans la première partie de cette thèse ont pour principal objectif d'élargir l'éventail des réactions actuellement disponibles en KTGS grâce à la réaction d'aldolisation voire d'amidation, et ce en utilisant la β-sécrétase (BACE-1) comme cible biologique, qui est une enzyme étroitement impliquée dans la maladie d'Alzheimer. La seconde partie de cette thèse a été consacrée à la synthèse de marqueurs de masse fluorescents bioconjugables basés sur l'association d'un noyau coumarinique et d'une fonction phosphonium. Les deux générations présentées dans ce manuscrit ont entre autre permis de synthétiser une sonde FRET permettant de détecter l'activité enzymatique de la BACE-1, qui pourrait par ailleurs être un outil intéressant pour l'analyse des bruts réactionnels des réactions de click in situ,et diminuer les quantités d'enzyme engagées dans ces expériences. Enfin dans la dernière partie de cette thèse nous décrivons la mise au point de nouvelles réactions de conjugaison bio-orthogonale pour le marquage de molécules comportant une fonction aldéhyde. Nous avons ainsi développé d'une part une réaction trois composants via une séquence de condensation/Mannich/lactamisation et d'autre part une réaction d'oléfination de Wittig. / The kinetic target-guided synthesis (KTGS), is an underexplored alternative approach to combinatorial chemistry, in which the biological target is able to assemble its own inhibitors from a pool of fragments. Thus, the first part of this thesis aimed at extending the scope of the reactions available for the KTGS, by investigating the aldolisation and amidation reaction, using the β-secretase (BACE-1) as biological target, which is an enzyme narrowly involved in the Alzheimer's disease. The second part of this thesis was dedicated to the synthesis of bioconjagatable fluorophores containing a phosphonium group as mass tag associated to a coumarin core. Both generations presented in this manuscript allowed us, among other things, to synthesize a FRET probe that proved suitable for the determination of BACE-1 enzymatic activity. The utility of such a fluorogenic tool could be leveraged to facilitate the analysis of crude mixtures obtained during KTGS experiments, and lessen the amount of enzyme required in these experiments. Finally, in the last part of this thesis, we describe the development of two new bioorthogonal reactions allowing the selective labeling of molecules containing an aldehyde moiety : 1) a three component reaction involving a condensation/Mannich/lactamisation procedure, between an amine, an aldehyde and an enol partner; 2) a Wittig ligation between an aldehyde and a phosphonium bearing an active methylene.

Photoaffinity labeling is a quintessential technique in studying and analyzing the interaction between a ligand and receptor. Diazirines are one of the important photo-labile moieties used in photoaffinity labeling due to their superior photo labeling characteristics. Herein, we report the investigations we conducted with diazirine photolabels on (a) photochemical aspects leading to enhancement of their ambient light stability and (b) equipping them with fluorous tags to enable fluorous enrichment of labeled proteins. Furthermore, we report a pilot study to develop BACE-1 inhibitors, which have potential to be developed into photoaffinity probes. 3-Trifluoromethyl-3-phenyldiazirine offers good selectivity and protection against pseudolabeling but due to its photo lability, it undergoes decomposition even under ambient light. Thus the laboratory handling, including synthesis, of 3-trifluoromethyl-3-phenyldiazirine is cumbersome and restricted under constant darkness. Herein, we have designed, synthesized and evaluated two photolabels with enhanced stability to ambient light conditions in addition to the good selectivity and protection against pseudolabeling as offered by 3-trifluoromethyl-3-phenyldiazirine. It was also found that the aqueous solubility, a vital physical property for a photolabel, was also improved in the modified ambient light stable photolabels. Fluorous tags have found wide use in synthetic applications; herein we explore the possibility of its application in photoaffinity studies. We designed, synthesized and conducted photoactivation studies on two fluorous diazirine photolabels. The photoactivation studies unraveled an unanticipated photoreaction when the fluorous tag was directly connected to the diazirine ring, yielding a fluorous alkene. The more practical photolabel of the two was chosen as the target specific photoaffinity labeling moiety for fluorous proteomics. Upon conducting photolabeling experiments under various conditions, we found that the strong hydrophobic character of the fluorous tag renders the photoaffinity label insoluble in aqueous solutions and significantly alters the binding mode and affinity of the photoaffinity label to its target receptor. A library of 1,3-disubstituted 2-propanols was combinatorially prepared and tested as small molecule inhibitors of β-secretase (BACE-1). The initial screening of the 1,3-disubstituted 2-propanol library revealed a few low micromolar inhibitors for BACE-1. The compound that showed the best activity was chosen for further SAR studies, which resulted in a potent BACE-1 inhibitor with nanomolar inhibition. Investigation on the selectivity of these compounds for BACE-1 inhibition over cathepsin D revealed that these compound series possess very high selectivity. Furthermore, the physicochemical properties study showed that these compounds possessed the calculated parameters advantageous to cross the blood-brain barrier (BBB).

This thesis describes work done to design and synthesize protease inhibitors, with the intention of developing therapeutic agents for Alzheimer’s disease (AD) and the chronic liver condition caused by infection of the hepatitis C virus (HCV). AD is the most common form of dementia, and HCV infection is the primary reason for liver transplantation in industrialized countries. Today, these two illnesses affect 24 and 170 million people, respectively. It has been shown that the human aspartic protease BACE-1 plays an important role in the development of AD, and thus inhibition of BACE-1 may offer a way to improve the quality of life of individuals afflicted with the disease. Furthermore, it is known that the serine protease NS3 is a vital component in the replication of HCV. Several novel potent BACE-1 inhibitors encompassing different transition state mimics were prepared. First, a hydroxyethylene moiety encompassing a secondary hydroxyl group was evaluated as a transition state analogue, producing inhibitors in the low nanomolar range. Various tertiary hydroxyl isosteres were also investigated as the central core, with the aim of shielding the pivotal hydroxyl group. These transition state isosteres consisted of tertiary hydroxyl analogues of previously used secondary hydroxyl containing norstatine, statine, and hydroxyethylamine isosteres. Several tertiary hydroxyl-containing inhibitors were found to be active in the low micromolar range. In addition, two inhibitors were co-crystallized with the BACE-1 enzyme to provide X-ray crystal structures, which furnished valuable binding information for further design of improved BACE-1 inhibitors. The goal in the HCV NS3 protease inhibitor project was to design, synthesize and evaluate a novel hydroxycyclopentene bioisostere to the previously used acyl-hydroxyproline moiety. The investigation revealed that it was possible to synthesize inhibitors containing this new bioisostere that were potent in the low nanomolar range. Further optimization by rigidification of the most active inhibitor resulted in equipotent macrocyclic compounds.